Key Metrics
SJR 

Q4Pharmacology

Recommended pre-submission checks
Powered by 

Prescrire International Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | Association Mieux Prescrire |
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in Prescrire International
Natalizumab: retinal necrosis.
- 1 May 2017
- Prescrire international
Rosacea First-choice treatments.
- 1 May 2017
- Prescrire international
Sufentanil sublingual tablets (Zalviso°) and postoperative analgesia.
- 1 May 2017
- Prescrire international
Insulin degludec + liraglutide (Xultophy°) in type 2 diabetes.
- 1 May 2017
- Prescrire international
Pembrolizumab (Keytruda°) and metastatic or inoperable melanoma.
- 1 May 2017
- Prescrire international
New products and new indications in 2016: a system that favours imitation over the pursuit of real progress.
- 1 May 2017
- Prescrire international
Natalizumab: retinal necrosis.
- 1 May 2017
- Prescrire international
Rosacea First-choice treatments.
- 1 May 2017
- Prescrire international
Sufentanil sublingual tablets (Zalviso°) and postoperative analgesia.
- 1 May 2017
- Prescrire international
Insulin degludec + liraglutide (Xultophy°) in type 2 diabetes.
- 1 May 2017
- Prescrire international
Pembrolizumab (Keytruda°) and metastatic or inoperable melanoma.
- 1 May 2017
- Prescrire international
New products and new indications in 2016: a system that favours imitation over the pursuit of real progress.
- 1 May 2017
- Prescrire international